Evidence map›Paper›PMID 42113825›Full record

ArticlePLoS neglected tropical diseases2026

Outbreak of dengue fever in Ghana: The emergence of DENV-1 serotype.

Deborah Pratt, Yaw Awuku Larbi, Magdalene Ofori, Bright Agbodzi, Jessica Wiley, Ama O A Mante, Selassie Kumordjie, Miriam Eshun, Stella Bour, Nancy Enimil and 18 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Rapid urban evolution of the dengue mosquito in West African cities.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Deborah PrattVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Yaw Awuku LarbiVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Magdalene OforiVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Bright AgbodziNaval Medical Unit EURAFCENT, Accra, Ghana.
Jessica WileyPathoSeq Bio LLC, Omaha, Nebraska, United States of America.
Ama O A ManteVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Selassie KumordjieNaval Medical Unit EURAFCENT, Accra, Ghana.
Miriam EshunVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Stella BourVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Nancy EnimilVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Juliana N D Acquah-AmaningVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Prince KetorwoleyVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Maame S BoapeaVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
David D NutakorVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Musah SalisuVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Gertrude StephensVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Emmanuel A BoatengVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Tracy AdjandehVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Joel KoomsonVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Dennis LaryeaPublic Health Division, Ghana Health Service, Ministry of Health, Accra, Ghana.
Franklin Asiedu-BekoePublic Health Division, Ghana Health Service, Ministry of Health, Accra, Ghana.
Patrick Kuma-AboagyePublic Health Division, Ghana Health Service, Ministry of Health, Accra, Ghana.
Patrick Mawupemor AvevorCountry Office Accra, World Health Organization, Accra, Ghana.
Argata G GurachaCountry Office Accra, World Health Organization, Accra, Ghana.
Sally-Ann OheneCountry Office Accra, World Health Organization, Accra, Ghana.
Terrel SandersNaval Medical Unit EURAFCENT, Accra, Ghana.
Michael WileyNaval Medical Unit EURAFCENT, Accra, Ghana.
Joseph Humphrey Kofi BonneyVirology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.ORCID https://orcid.org/0000-0003-0301-8145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDengue, a mosquito-borne virus continues to be a public health concern in the tropics and subtropical parts of Africa. Due to the increase of urbanization, climate change and trans-Atlantic trade, the transmitting vector, Aedes aegypti, has become prevalent hence the rapid growth of the disease, globally. In Ghana, there have been sporadic laboratory-confirmed cases of dengue reported over the years through surveillance activities. However, despite the detection of these cases, Ghana had never experienced a major outbreak (unlike its neighboring countries) until July 2024.

methodsDuring this outbreak, a total of 1471 suspected dengue fever specimen received from various health facilities in Ghana in NMIMR for molecular diagnostic testing using a RT-qPCR assay for dengue, chikungunya and Zika viruses and selected positives sequenced using Illumina Next Generation Sequencing.

resultsDengue fever virus RNA was detected from 206 samples and serotyped as DENV-1 with one DENV-3 coinfection. Thirty-nine genomes were successfully generated after sequencing and phylogenetic analysis of DENV-1 strains revealed two main clusters with AFI isolates in Ghana and isolates from other West African countries (Côte d'Ivoire, Burkina Faso, Benin, and Senegal) circulating between 2017-2019. In 2023, DENV-1 was frequently isolated which could account for it being the predominant serotype transmitted in the recent outbreak.

conclusionThe outbreak response and the case management procedures deployed by the health authorities during this outbreak were swift and was enough to prevent a fatal difficult-to-control situation. With the absence of a widely accepted commercialized vaccine and treatment for dengue fever, there is a need to enhance surveillance activities and control the vectors which can transmit DENV in-country to curb the occurrence of outbreaks.

Indexed as

DengueDengue VirusDisease OutbreaksAdolescentAdultChildFemaleGenome, ViralGhanaHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMolecular Diagnostic TechniquesPhylogenyPrevalenceRNA, Viral

Identifiers

PMID42113825
PMCPMC13215617

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.